Vanguard Portfolio Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25B Sell
20,859,217
-117,810
-0.6% -$120M 1.13% 9
2026
Q1
$19.3B Buy
+20,977,027
New +$21.3B 1.01% 10

Other funds holding LLY

Vanguard Portfolio Management's LLY Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Eli Lilly (LLY) stake by 0.56% in Q2 2026, selling an estimated $120M and leaving 20,859,217 shares worth $25B. The position accounts for 1.13% of the portfolio, ranked #9.

Vanguard Portfolio Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vanguard Portfolio Management held 20,859,217 shares of Eli Lilly worth $25B as of Q2 2026.
  • Vanguard Portfolio Management sold 117,810 Eli Lilly shares in Q2 2026, an estimated $120M.
  • Eli Lilly made up 1.13% of Vanguard Portfolio Management's portfolio in Q2 2026, its #9 holding.
  • Vanguard Portfolio Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.